NCT00096811
No Longer Available
Not Applicable
A Treatment Use Protocol of Entecavir in Subjects With Chronic Hepatitis B Infection Who Have Failed or Who Are Intolerant of Available Therapies
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hepatitis B
- Sponsor
- Bristol-Myers Squibb
- Locations
- 1
- Status
- No Longer Available
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this clinical research study is to provide entecavir to subjects with chronic Hepatitis B infection who have failed or who have demonstrated intolerance of marketed therapies or for those in whom use of these agents is contraindicated and that have no other available treatment options.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hepatitis B Early Access Program
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Entecavir for Chronic Hepatitis BEntecavir for Chronic Hepatitis B PatientsNCT01323452Foundation for Liver Research418
Completed
Phase 4
A open-label study of entecavir for chronic hepatitis B to determine the optimum duration of administratiochronic hepatitis BJPRN-UMIN000000644Gunma Liver Study Group70
Unknown
Phase 4
Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver TransplantationHepatitis BLiver TransplantationNCT02417207Third Affiliated Hospital, Sun Yat-Sen University60
Completed
Phase 3
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus InfectionHepatitis B, ChronicNCT00395018Bristol-Myers Squibb109
Completed
Phase 4
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) InfectionHepatitis B InfectionNCT00371150Bristol-Myers Squibb131